Cargando…
Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
The development of anti-drug antibodies (ADAs) is a common cause for treatment failure and hypersensitivity reactions for many biologics. The focus of this review is the development of ImmTOR, a platform technology designed to prevent the formation of ADAs that can be applied broadly across a wide v...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7251066/ https://www.ncbi.nlm.nih.gov/pubmed/32508839 http://dx.doi.org/10.3389/fimmu.2020.00969 |